Wake Forest University School of Medicine receives NIH grant to study non-opioid migraine treatment
The Wake Forest University School of Medicine has received funding to study non-opioid treatments for migraines.
migraines
Medical Students Say Their Opioid Experiences Will Shape How They Prescribe
One medical student was addicted to opioids. Another relied on them to control disabling pain. Both think their experiences will help them be better doctors when it comes to prescribing opioids.
New Type Of Drug To Prevent Migraines Heads To Market
An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.
Gone With A Shot? Hopeful New Signs Of Relief For Migraine Sufferers
Novel migraine therapies could change how physicians treat these debilitating headaches. But they are likely to be expensive and the long-term side effects will not be known for some time.
New Drugs Could Prevent Migraine Headaches For Some People
The first drugs designed specifically to prevent migraines have been found safe and effective in studies, but aren't yet FDA approved. Both drugs work by tweaking a brain system involved in pain.
For Headaches, A Lifestyle Change May Be Better Than A Doctor Visit
Each year more than 12 million Americans go to the doctor because of severe, chronic headaches. Many are sent for expensive tests. Researchers say all this testing isn't doing people much good.
A Sleep Gene Has A Surprising Role In Migraines
Disruptions of sleep are well known as migraine triggers, but now researchers have found a genetic link between the two. In studying families with lots of migraines, they also found a mutation on a gene that helps control circadian rhythms.